▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #765 by analyst upside · 2026-11-14
RZLT
Rezolute, Inc.
Healthcare · Market Cap $354M · P/E 0x
ANALYST PRICE TARGET
+184.5%
implied upside to consensus target
Current Price $3.65
Consensus Target $10.4
Bull Target $15.0
Bear Target $6.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
8
Hold
0
Sell
0
52-Week Low $1.07
52-Week High $11.16
YTD Return +68.8%
FUNDAMENTALS
Market Cap $354M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-0.76
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $1.07
52-Week High $11.16
Current Price $3.65
Bear Target $6.0
Bull Target $15.0
● Now $3.65 ● Target $10.4
TRADING DATA
Avg Volume 1.5M
YTD Return +68.8%
Analyst Count 10
Consensus Buy
Upside to Target +184.5%
Last Updated 2026-11-14

ANALYST SUMMARY

Rezolute, Inc. (RZLT) is currently trading at $3.65 with a Wall Street consensus price target of $10.4, implying potential upside of 184.5% over the next 12 months. 10 analysts currently cover RZLT, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $15.0, while the most cautious has a target of $6.0.

RZLT operates in the Healthcare sector with a market capitalisation of $354M. The stock is up 68.8% year-to-date and is currently trading near the lower end of its 52-week range of $1.07 – $11.16.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RZLT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Lake Street - Reiterated
Buy → Buy 2026-10-06 27% win rate (11 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-10-06 Building track record
Cantor Fitzgerald ↑ Upgrade
Neutral → Overweight 2026-10-06 40% win rate (10 calls)
Lake Street ● Initiated
Buy 2026-09-30 27% win rate (11 calls)
Craig-Hallum ↑ Upgrade
Hold → Buy 2026-09-29 Building track record
HC Wainwright & Co. - Reiterated
Buy → Buy 2026-09-25 31% win rate (48 calls)
Guggenheim - Reiterated
Buy → Buy 2026-06-15 62% win rate (8 calls)
Maxim Group - Reiterated
Buy → Buy 2026-06-03 28% win rate (40 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
18/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →